T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis

Shreeya Kedia1,2, Hao Ji3, Ruoqing Feng1,2

  • 1Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.

Nature Neuroscience
|June 27, 2024
PubMed

Insights

Alzheimer's disease amyloidosis triggers myelin damage via immune cells. This suggests that immune responses targeting myelin may worsen neurodegeneration in Alzheimer's disease.

Area of Science:

  • Neuroimmunology
  • Neurodegeneration
  • Myelin Biology

Background:

  • Age-related myelin damage is linked to inflammation, but its role in Alzheimer's disease (AD) is unclear.
  • Age is a significant risk factor for Alzheimer's disease.
  • The precise mechanisms linking AD pathology to myelin integrity are not fully understood.

Purpose of the Study:

  • To investigate whether amyloidosis, a hallmark of Alzheimer's disease, directly causes age-related myelin damage.
  • To elucidate the cellular and molecular mechanisms underlying amyloid-induced myelin pathology.
  • To explore the potential contribution of immune responses against myelin to neurodegeneration in AD.

Main Methods:

  • Utilized a mouse model of Alzheimer's disease.
  • Examined oligodendrocyte and myelin integrity in the context of amyloidosis.
  • Investigated the role of CD8+ T cells and microglia activation states.

Main Results:

  • Amyloidosis was found to trigger age-related damage to oligodendrocytes and myelin.
  • CD8+ T cells were identified as drivers of microglial accumulation.
  • Abnormally interferon-activated microglia exhibited myelin-damaging properties.

Conclusions:

  • Amyloidosis directly induces age-related myelin damage in a mouse model of Alzheimer's disease.
  • Immune responses, particularly involving CD8+ T cells and activated microglia, are central to this process.
  • Immune-mediated damage to myelinating oligodendrocytes may contribute to neurodegeneration in amyloid-positive diseases like Alzheimer's.

Related Concept Videos